February 2011 - Volume 18 - Issue 2
pp: 119-240



Somatic and affective anxiety symptoms and menopausal hot flashes

Lermer, Miriam A.; Morra, Angela; Moineddin, Rahim; More

Menopause. 18(2):129-132, February 2011.

Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level?

van Altena, Anne M.; Holtsema, Hilda; Hendriks, Jan C.; More

Menopause. 18(2):133-137, February 2011.

Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition

Yang, Yun Seok; Hur, Myung Haeng; Kim, Soo Young; More

Menopause. 18(2):138-145, February 2011.

Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease

Gast, Gerrie-Cor M.; Pop, Victor J.M.; Samsioe, Göran N.; More

Menopause. 18(2):146-151, February 2011.

Dyspareunia is associated with decreased frequency of intercourse in the menopausal transition

Thomas, Holly M.; Bryce, Cindy L.; Ness, Roberta B.; More

Menopause. 18(2):152-157, February 2011.

Menopause in women with type 1 diabetes

Sjöberg, Lena; Pitkäniemi, Janne; Harjutsalo, Valma; More

Menopause. 18(2):158-163, February 2011.

Is long-term bisphosphonate therapy associated with benefits to the periodontium in postmenopausal women?

Palomo, Leena; Buencamino-Francisco, Maria Clarinda A.; Carey, John J.; More

Menopause. 18(2):164-170, February 2011.

Type of hormone therapy and risk of misclassification at mammography screening

Njor, Sisse H.; Hallas, Jesper; Schwartz, Walter; More

Menopause. 18(2):171-177, February 2011.

Isoflavones decrease insomnia in postmenopause

Hachul, Helena; Brandão, Letícia Campos; D'Almeida, Vânia; More

Menopause. 18(2):178-184, February 2011.

Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms

Jackson, Richard L.; Greiwe, Jeffrey S.; Desai, Pankaj B.; More

Menopause. 18(2):185-193, February 2011.

Quercetin-6-C-β-d-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone...

Siddiqui, Jawed A.; Sharan, Kunal; Swarnkar, Gaurav; More

Menopause. 18(2):198-207, February 2011.

Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea

Najafi, Safa; Esmaeeli Djavid, Gholamreza; Mehrdad, Neda; More

Menopause. 18(2):208-212, February 2011.

The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats

Czerny, Boguslaw; Teister, Maria; Juzyszyn, Zygmunt; More

Menopause. 18(2):213-218, February 2011.


Postmenopausal hormone therapy initiation before and after the Women's Health Initiative in two French cohorts

Fournier, Agnès; Kernaleguen, Céline; Panjo, Henri; More

Menopause. 18(2):219-223, February 2011.

Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole

Van Calster, Ben; Van Ginderachter, Johan; Vlasselaer, Jos; More

Menopause. 18(2):224-229, February 2011.


The Timing Hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatment

Choi, Seung Do; Steinberg, Emma M.; Lee, Hae Hyeog; More

Menopause. 18(2):230-236, February 2011.


Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation

Lobo, Rogerio A.; Clarkson, Tom B.

Menopause. 18(2):237-240, February 2011.

1 2 3 4 5